Tag:
SAM-101
Latest Headlines
Latest Headlines
XTL snags schizophrenia drug in exclusive licensing pact
XTL Biopharmaceuticals ( $XTLB ) has struck an interesting deal to land a badly-needed late-stage therapy for its pipeline. The company gained an exclusive license for all the technology on hand at
